| - Industry | - Sector | Mr. Naveen Krishnarao Kulkarni CEO | OTC PINK Exchange | - ISIN |
| US Country | 1 Employees | - Last Dividend | 23 May 2023 Last Split | - IPO Date |
Quantum Genesis AI Corp., previously known as Quantumzyme Corp., is a pioneering biotransformation company that specializes in the development of enzyme-based solutions tailored for pharmaceutical manufacturing. Established in 2015 and located in San Diego, California, the company leverages cutting-edge technologies, including quantum mechanics, molecular modeling, and AI-driven simulations, to revolutionize the field of biocatalysis. Their focus on customer-centric research drives their innovations, enhancing enzyme activity to promote efficiency while significantly reducing waste in production processes. In February 2026, the company rebranded as Quantum Genesis AI Corp., representing its commitment to utilizing advanced artificial intelligence methodologies in its enzyme engineering endeavors.
Quantum Genesis AI Corp. offers tailored enzyme solutions designed for specific pharmaceutical applications. By utilizing advanced computational enzyme engineering techniques, the company creates bespoke biocatalysts that meet the unique requirements of its clients, enhancing production efficiency and sustainability.
The company provides innovative simulation tools powered by artificial intelligence which allow clients to model enzyme behavior and predict performance. These tools help in optimizing enzyme formulations and processes, streamlining experimental workflows, and reducing the time from development to market.
Quantum Genesis AI Corp. employs state-of-the-art molecular modeling methodologies to visualize enzyme interactions and optimize their structures. This service aids in the rational design of enzymes, providing insights that lead to improved activity and stability under various manufacturing conditions.
With extensive expertise in biocatalysis, the company offers consulting services to pharmaceutical manufacturers looking to integrate enzyme solutions into their production lines. Quantum Genesis AI Corp. assists in identifying opportunities for biotransformation and optimizing existing processes using their advanced enzymatic technologies.
The sustainability assessment service evaluates the environmental impact of current manufacturing processes. By analyzing waste generation, energy usage, and resource conservation, Quantum Genesis AI Corp. recommends enzyme-based solutions to enhance sustainability in pharmaceuticals.